Acute lymphoblastic leukemia, the most common pediatric cancer, has been the subject of a new study. Newly identified genetic markers could improve the classification of risk groups and predict treatment toxicity in the patient.
Acute lymphoblastic leukemia, the most common pediatric cancer, has been the subject of a new study. Newly identified genetic markers could improve the classification of risk groups and predict treatment toxicity in the patient.